AMGN stock verdict - Avoid
AMGN
Amgen Inc.
AVOIDHealthcare
$376.26
Fundamentals below bar
$376.26
Heavy$168.82Buy$225.09Fair$281.36Exit$337.64
FUNDAMENTAL42
TECHNICAL100
TRUST SCORE
30Very Low
confidence in this read — data completeness, earnings quality & coverage
Uptrend · EMA20 363.49 · EMA50 355.59 · EMA200 339.95 · RSI 64.1 · MACD above signal
PROS
- High gross margin of 71% (3-yr avg)
- Price is in an uptrend — above key moving averages with positive momentum
CONS
- Trades above the model's exit level ($337.64) — overvalued on this framework
- Rich for its growth rate (PEG 3.6)
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
SECTOR PEERS
Analysis as of 2026-07-28 · price live, fundamentals from latest filings
FAQ
Why is AMGN rated Avoid?
AMGN (Amgen Inc.) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Fundamentals below bar. High gross margin of 71% (3-yr avg) and Price is in an uptrend — above key moving averages with positive momentum
Is AMGN overvalued right now?
AMGN is trading at $376.26 versus an estimated fair value of $281.36. That puts the stock in avoid territory on this framework. Trades above the model's exit level ($337.64) — overvalued on this framework and Rich for its growth rate (PEG 3.6)
What should I watch before acting on AMGN?
Watch the trust score of 30, the earnings-quality checks, and any red flags. Trades above the model's exit level ($337.64) — overvalued on this framework and Rich for its growth rate (PEG 3.6)